250 drugs have applied to be removed from the Internet and will be shut down soon

[industry trends of pharmaceutical network] recently, Hainan Provincial Pharmaceutical centralized purchasing center issued the notice on publicizing the withdrawal of some drugs from the Internet (January 8, 2020), and 250 drugs applied for withdrawal from the Internet According to the notice, these are the drug withdrawal applications accepted since April 2019 The publicity period is from January 8, 2020 to January 14, 2020 After the expiration of the publicity period, the drugs without objection will be removed from the Internet It is worth noting that 171 of the drugs applying for cancellation of the network suspension are shut down due to rising production costs, abnormal supply, production line transformation, production line stop and other reasons In recent years, in fact, there have been a number of drug withdrawal applications by enterprises, most of which are related to the rising cost of drugs and the low price of the Internet As we all know, in recent years, the price of drugs has been squeezed more and more low under various policies such as centralized drug purchase and volume purchase In order to keep the market, some manufacturers are willing to fight a price war and disturb the price system of their own products Under the national linkage mechanism of drug prices, they have to stop production because of their meager profits or even no money at all Some of the drugs are abandoned because of the rising cost of raw materials and production year by year, the low price of drugs and the unprofitable enterprises In fact, drug withdrawal is also a common phenomenon in the pharmaceutical industry in the past two years But medicine is closely related to national health The state has always attached great importance to the price and cost of medicine As early as June 2017, nine departments including the national health and Family Planning Commission jointly issued the opinions on the implementation of reform and improvement of the supply guarantee mechanism of drugs in short supply, which proposed that we should emphasize the establishment of a long-term mechanism, pay attention to joint consultation, improve the drug supply guarantee system, and strive to form a supply guarantee mechanism of drugs in short supply with Chinese characteristics by 2020 In October 2019, the state issued the opinions on further ensuring the supply and price stability of short drugs, to improve the sensitivity and timeliness of monitoring response, to strengthen the allocation and use of basic drugs in medical institutions and the standardized management of drug use, to improve the purchase of short drugs, to increase the supervision and law enforcement of drug prices, and to improve the multi-level supply system of short drugs Recently, the office of the State Medical Insurance Bureau issued the notice on drug price management at this stage, in which the price control mentioned that: relying on the provincial drug bidding and purchasing institutions, promoting the construction of regional and national drug alliance purchasing mechanism, unifying coding, standards and functional specifications, promoting information interconnection, resource sharing and policy linkage Deepen the "deregulation service", on the basis of respecting the market rules and the independent pricing power of operators, comprehensively use monitoring and early warning, correspondence and interview, warning and warning, cost investigation, credit evaluation, information disclosure and other means, establish and improve the regulatory mechanism of drug price normalization, and promote operators to strengthen price self-discipline
According to the industry, to ensure the stability of drug prices, a long-term supply guarantee mechanism needs to be developed According to the implementation opinions on reforming and improving the supply guarantee mechanism of short drugs, by 2020, drugs will realize the sharing and sharing of comprehensive supply guarantee management and shortage monitoring and early warning information resources, and establish a mature and stable real-time monitoring and early warning and hierarchical response system for short drugs 。 With the establishment of the mechanism to guarantee the supply of drugs in short supply, more and more drug shortages may be alleviated to ensure the normal supply of drugs for patients.